Product Images Memantine Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Memantine Hydrochloride NDC 43353-170 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The given text is a graph showing the cumulative percentage of patients against the SIB (Severe Impairment Battery) change from baseline for two different treatments, placebo and memantine. The graph has 10 intervals with values not clearly visible.*
The text describes a clinical study that measures changes in the ADCS-ADL score over time. The study assesses clinical improvement by analyzing the mean change in the score from baseline, but also evaluates clinical decline. The results are measured over a period of 8 weeks of treatment.*
The text is a graph showing the cumulative percentage of patients on Placebo/Donepezil and Memantine/Donepezil, with ADCS-ADL change from Baseline to indicate the effectiveness of the drugs.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.